Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha1-PI in New-Onset Type 1 Diabetes
NCT02093221Phase 2Terminated
- Sponsor
- Grifols
- Start
- Mar 2014
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha1-proteinase inhibitor in type 1 diabetes mellitus (T1D), sponsored by Grifols. Started Mar 2014; status: terminated.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02093221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093221.